Press Releases

Jan 06, 2022
Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research
Jan 05, 2022
Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants
Jan 04, 2022
Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference